Obezite ve Kalp

Obezite, 1980 yılı başlarından günümüze yaklaşık olarak 2 kat artış göstermiş olup, bu alandaki tüm medikal gelişmelere rağmen, dünya genelinde, yaygın halk sağlığı sorunu olmaya devam etmektedir. Obezite, bilindiği üzere kalp hastalıkları açısından kanıtlanmış bir risk faktörüdür. Ancak kalp hastalıkları için risk teşkil eden diabetes mellitus (DM), hipertansiyon (HT) ve hiperlipidemi (HL) gibi diğer durumlar, obeziteye sıklıkla eşlik ettikle-ri için, tek başına obezitenin kalp hastalıklarına olan risk katkısı hȃlȃ net değildir. Bununla birlikte güncel veriler, obezitenin sağlıklı sonuçlarla da ilişkili olabileceğini göstermektedir. Dolayısıyla metabolik sağlıklı obezite, obezite paradoksu, koruyucu subkutan yağ deposu gibi kavramlar, obezite tanısı konulurken kapsamlı değerlendirilmelidir.

Obesity and Heart

Despite all medical improvements, obesity rates have almost doubled since the 1980's and it's still a common public healthcare problem worldwide. Obesity is a well established risk factor for cardiac diseases. Since other issues such as diabetes mellitus (DM), hypertension (HT) and hyperlipidemia (HL) are often accompanied with obesity, it's own contrubition to cardiac risk is not clearly explained. Current knowledge in this area has opened up some definitions that may lead to different assessments like; obesity may also be associated with healty outcomes. Concepts such as metabolic healthy obesity, obesity paradox and protective subcutaneous fat storages require comprehensive assessment when diagnosing obesity and careful considera-tion of subgroups related to future healty outcomes.

___

Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophy-siology. JAMA 2009; 301: 2129.
Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evalu-ation, and effect of weight loss: Man update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutri-tion, Physical Activity, and Metabolism. Circu-lation 2006; 113: 898-918.
Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual pre-sents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 9: 4145–50.
Clinical Guidelines on the Identification, Evalu-ation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Insti-tutes of Health. Obes Res 1998; 6: 51-209.
Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 28: 1083-96.
Romerro-Coral A, Montori VM, Somers VK, et al. Association of bodyweight with total morta-lity and with cardiovascular events in coronary artery disease; a systematic review of cohort studies. Lancet 2006; 368: 666-78.
Gruberg L, Weismann NJ, Waksmann R, et al. The impact of obesity on the short-term and long term outcomes after percutaneus coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39: 578.
Yusuf S, Hawken S, Ounpuu S,et al. INTER-HEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 partici-pants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
Coutinho T, Goel K, Corre ˆa de Sa ´D, et al. Central obesity and survival in subjects with co-ronary artery disease: a systematic review of the literature and collaborative analysis with indivi-dual subject data. J Am Coll Cardiol 2011; 57: 1877-86.
Lim S, Quon MJ, Koh KK. Modulation of adi-ponectin as a potential therapeutic strategy. At-herosclerosis 2014; 233: 721-8.
Frayn KN. Insulin resistance, impaired postp-randial lipid metabolism and abdominal obesity. A dadly triad. Med Princ Pract 2002; 11: 31-40.
Sierra-Johnson J, Romero-Corral A, Lo´ pezJi-me´nez F, et al. Relation of increased leptin concentrations to history of myocardial infarc-tion and stroke in the United States population. Am J Cardiol 2007; 100: 234-9.
Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, et al. Separa-te and combined associations of body-mass in-dex and abdominal adiposity with cardiovascu-lar disease: collaborative analysis of 58 prospec-tive studies. Lancet 2011; 377:1085
Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardi-ovascular disease: a 26-year follow-up of parti-cipants in the Framingham Heart Study. Circu-lation 1983; 67: 968-77.
Baker JL, Olsen LW, Sørensen TI. Childhood bodymass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 23-9.
Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013; 7: 85–94.
Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of ty-pe 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–12.
Karelis AD, MessierV, BrochuM, et al. Metabo-lically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51: 1752-4.
Shimabukuro M, Hirata Y, Tabata M, et al. Epicardial adipose tissue volume and adipocy-tokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 1077–84.
Al Chekakie MO, Welles CC, Metoyer R, et al. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 2010; 56: 784–8.
Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hy-pertens 1989; 2: 1255-325.
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–13.
Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29.
Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The re-lationship between obesity and mortality in pa-tients with heart failure. J Am Coll Cardiol 2001; 38: 789.
T.J. Wang, H. Parise, D. Levy, et al. Obesity and the risk of new-onset atrial fibrillation JAMA 2004; 292: 2471-7.
Tedrow UB, Conen D, Ridker PM, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol 2010; 55: 2319-27.
Parkash R, Green MS, Kerr CR, et al. The asso-ciation of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004; 148: 649-54.
Olshansky B, Heller EN, Mitchell LB, et al. Are transthoracic echocardiographic parameters as-sociated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Fol-low-Up Investigation of Rhythm Management (AFFIRM) study. J AmColl Cardiol 2005 21; 45: 2026-33.
Abhayaratna WP, Fatema K, Barnes ME, et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons > or = 65 years of age. Am J Cardiol 2008; 101: 1626-9.
Abel ED, Litwin SE, Sweeney G. Cardiac re-modeling in obesity. Physiol Rev 2008; 88: 389-419.
Esposito K, Nicolletti G, Marzano S, et al. Au-tonomic dysfunction associates with prolonga-tion of QT intervals and blunted night BP ino-bese women with visceral obesity. J Endocrinol Invest 2002; 25: 32–5.
Huang H, Amin V, Gurin M, et al. Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium chan-nels. J Mol Cell Cardiol 2013; 59: 151-8.
McCully BH, Hasan W, Streiff CT, et al. Sym-pathetic cardiac hyperinnervation and atrial au-tonomic imbalance in diet-induced obesity pro-mote cardiac arrhythmias. Am J Physiol Heart Circ Physiol 2013; 305: 1530-7.